Navigation Links
Winner Medical Group Inc. to Host Third Quarter Fiscal Year 2010 Earnings Conference Call on Wednesday, August 11, 2010 at 10:00 a.m. EDT
Date:7/30/2010

SHENZHEN, China, July 30 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN; "Winner Medical" or the "Company"), a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton(R) materials for the medical and consumer products industries, today announced that it will release financial results for the third quarter of fiscal year 2010 on Wednesday, August 11, before the market opens. Winner Medical's senior management will host a conference call to discuss these results at 10:00 a.m. EDT on August 11, 2010.

    Date of the conference call: Wednesday, August 11, 2010
    Time: 10:00 a.m. EDT
    Dial-in Number: +1-800-561-2718 (US)
                    10-800-130-0399 (South China)
                    10-800-152-1490 (North China)
                    800-96-3844 (Hong Kong)
                    +1-617-614-3525 (International)
    Pass code: 42723804.

A telephone replay will be available shortly after the conclusion of the call and will be accessible through August 18, 2010 by calling +1-888-286-8010 (US) or +1-617-801-6888 (International); Pass code: 76980551.

The earnings release will be available on the investor relations page of Winner Medical's website at http://ir.winnermedical.com on Thursday, August 12, 2010 (EDT).

About Winner Medical:

Winner Medical is a leading manufacturer and the largest exporter by volume in the medical dressing industry in China. Headquartered in Shenzhen, the Company has eight wholly owned operating subsidiaries and four joint ventures with over 5,000 employees. The Company engages in the manufacturing, sale, research and development of medical care products, wound care products, home care products and PurCotton(R) products, a non-woven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the United States, China and Japan serving as the top four markets. The Company currently holds more than sixty patents and patent applications for various products and manufacturing processes and is one of the few Chinese companies licensed by the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the United States market. To learn more about Winner Medical, please visit Winner Medical's web site at: http://ir.winnermedical.com .

Forward-Looking Statements:

This press release contains certain statements that may include "forward- looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.

    For more information, please contact:

    Company:
     Peng Zhai
     Investor Relations Manager
     Winner Medical Group Inc.
     Tel:   +86-755-2806-6858
            +86-755-2813-8888 x691
     Email: investors@winnermedical.com
     Web:   http://ir.winnermedical.com

    Investors:
     Scott Powell
     HC International, Inc.
     Tel:   +1-917-721-9480
     Email: scott.powell@hcinternational.net
     Web:   http://www.hcinternational.net


'/>"/>
SOURCE Winner Medical Group Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
2. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
3. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
4. Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World
5. The Scientist Magazine Recognizes febits HybSelect(TM) Among the Winners of Top 10 Innovations of 2009
6. Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced
7. Winner Medical Participates in CMEF 2010, China International Medical Equipment Fair, in Shenzhen
8. Lakeside Behavioral Healthcare Named Winner of First Annual Netsmart Technologies Customer Innovation Award
9. Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock
10. NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
11. Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... -- The innovator of COMBO ... s first dual therapy stent, introduces catheters for lower ... a global company specializing in the provision of life-changing ... to treat peripheral artery disease. The JADE™ and Scoreflex™ ... lower limb and arteriovenous (AV) fistula intervention. ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse ... cathéters destinés à l,intervention portant sur les ...   OrbusNeich, entreprise mondiale spécialisée ... de changer la vie, a élargi son ...
Breaking Medicine Technology:
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the ... and suppliers for its inaugural Member Conference at the Paris Hotel in Las ... the operational health of America’s healthcare providers. , The conference was highlighted by ...
(Date:5/26/2016)... ... 2016 , ... The Woodlands at John Knox Village , Florida’s first ... for living and healing, celebrated its grand opening, today. The Woodlands at John Knox ... by Empowered Staff. , “This is an incredibly fulfilling time for John Knox Village ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... and development solutions for drugs, biologics, consumer health and global clinical supply services, ... in Korea to support the company’s continued investment and strategic growth plans in ...
Breaking Medicine News(10 mins):